|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flow from Operating Activities: | |||||
| Net Loss | |||||
| Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities: | |||||
| Share-Based Compensation | |||||
| Share-Based Payments to Vendors | |||||
| (Increase)/Decrease in: | |||||
| Other Receivable | |||||
| Prepaid Expenses | |||||
| Accounts Payable and Accrued Expenses | |||||
| Net Cash Used in Operating Activities | |||||
| Cash Flow from Financing Activities: | |||||
| Pre-funded Warrant Exercise | |||||
| Reverse Stock Split fractional share adjustment | |||||
| Proceeds from Warrant Inducement, net of issuance costs | |||||
| Proceeds from Warrant Exercise | |||||
| Proceeds from issuance of common stock in connection with equity line of credit purchase agreement, net of issuance costs | |||||
| Proceeds from 2025 March Registered Direct Offering, net of issuance costs | |||||
| Proceeds from 2025 January Registered Direct Offering, net of issuance costs | |||||
| Proceeds from At-the-Market Offering, net of issuance costs | |||||
| Net Cash Provided by Financing Activities | |||||
| Net Increase/(Decrease) in Cash | |||||
| Cash at Beginning of Year | |||||
| Cash at End of Year | |||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH OPERATING ACTIVITIES | |||||
| Share-Based Compensation to settle accrued compensation (Note 5) | |||||
| SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES | |||||
| 2023 Registered Direct offering costs (Note 4) | |||||
| 2025 Equity Line of Credit Purchase Agreement costs (Commitment shares)(Note 4) | |||||
| 2025 Warrant Inducement Financing costs (Note 4) | |||||
| Registered Direct Offering costs | |||||
| January 2025 Registered Direct Offering | |||||
| March 2025 Registered Direct Offering | |||||
Loading...
